Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalyst Pharm Inc (NQ: CPRX ) 21.75 -0.14 (-0.64%) Streaming Delayed Price Updated: 2:33 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 358,239 Open 21.82 Bid (Size) 21.74 (8) Ask (Size) 21.76 (4) Prev. Close 21.89 Today's Range 21.30 - 21.96 52wk Range 12.27 - 22.27 Shares Outstanding 102,780,151 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why NASDAQ:CPRX Is a Promising High-Growth Stock in the Midst of Consolidation. Today 5:20 EST CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX): a strong growth stock preparing for the next leg up?. Via Chartmill NASDAQ:CPRX, a growth stock which is not overvalued. October 30, 2024 NASDAQ:CPRX is showing decent growth, but is still valued reasonably. Via Chartmill Performance YTD +27.12% +27.12% 1 Month +8.75% +8.75% 3 Month +40.41% +40.41% 6 Month +45.10% +45.10% 1 Year +67.44% +67.44% More News Read More Biotech Momentum Trades For The Q4 Rally October 29, 2024 Via Talk Markets Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024 October 22, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade October 15, 2024 Via Investor's Business Daily NASDAQ:CPRX is showing good growth, while it is not too expensive. September 13, 2024 Via Chartmill Exploring the Growth Potential of NASDAQ:CPRX as It Nears a Breakout. August 29, 2024 Via Chartmill NASDAQ:CPRX—Positioned as a High-Growth Stock, Ready for a Potential Breakout. October 14, 2024 Via Chartmill Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits October 14, 2024 Via Investor's Business Daily Looking for growth without the hefty price tag? Consider NASDAQ:CPRX. October 09, 2024 Via Chartmill Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts October 08, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 October 01, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan September 24, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire A Biotech Breakout Will Be Led By Small Caps September 23, 2024 Via Talk Markets Topics Artificial Intelligence Economy Exposures Artificial Intelligence Interest Rates Why NASDAQ:CPRX Is a Standout High-Growth Stock in a Consolidation Phase. September 19, 2024 Via Chartmill Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark September 05, 2024 Via Investor's Business Daily Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers August 29, 2024 Via Investor's Business Daily Biohaven Stock Earns Relative Strength Rating Upgrade August 21, 2024 Via Investor's Business Daily SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating August 21, 2024 Via Investor's Business Daily Investors should take notice of NASDAQ:CPRX—it offers a great deal for the fundamentals it presents. August 21, 2024 Via Chartmill NASDAQ:CPRX stands out as a growth opportunity that won't break the bank. August 21, 2024 Via Chartmill Immunome Stock Sees RS Rating Jump To 91 August 20, 2024 Via Investor's Business Daily Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences August 20, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire PTC Therapeutics Stock Earns RS Rating Upgrade To 83 August 19, 2024 Via Investor's Business Daily Top 3 Health Care Stocks That May Crash In August August 14, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
